Limiting inverter output, called derating, enables installers to maintain system power rating when adding a new inverter to an existing solar installation, or to help homeowners qualify for incentives ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

UCB and Biogen say their first phase 3 trial of systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, with a second planned.

Here’s WAVE News meteorologist Carson Meredith with your forecast. Download the weather app from the WAVE News Storm Tracking Team LOUISVILLE, Ky. (WAVE) - An ALERT DAY is in place this evening as ...

Here’s WAVE News meteorologist Carson Meredith with your forecast. Download the weather app from the WAVE News Storm Tracking Team LOUISVILLE, Ky. (WAVE) - Heat Advisories are in place for most ...